In particular, recent studies have documented that adiponectin induces breast cancer cell death and growth arrest by regulating a wide range of cellular events, such as autophagy, tumor-promoting inflammation, inflammasomes activation, and oncogenic signals driven by leptin and estrogen [4–8]. Here, ADIPOQ is linked to breast cancer.